- Entry
- $1,003.46
- Final
- $1,117.26 +11.3%
- Target
- —
- Score
- +1.00
Source: [https://finance.yahoo.com/news/eli-lilly-sees-2026-profit-115421218.html](https://finance.yahoo.com/news/eli-lilly-sees-2026-profit-115421218.html) >Eli Lilly forecast 2026 profit above Wall Street estimates on Wednesday, betting on surging demand for its obesity drugs as the world's most valuable drugmaker prepares to launch its oral weight-loss pill later this year. >Shares of the company rose nearly 7% in premarket trading. >Lilly last year became the first pharmaceutical company to hit a $1 trillion valuation, driven by the popularity of its blockbuster weight-loss drug, Zepbound, and a rapidly expanding obesity market that is shifting …
— ORIGINAL POST ·
Eli Lilly +7% premarket after $7.54 EPS vs $6.67 and forecasting 2026 profit $33.50‑$35 on strong weight‑loss drug demand
· r/wallstreetbets
· Feb 4, 2026